Guoping Cheng

1.1k citations
38 papers · 808 indexed · h-index 16
Topics
Cancer Immunotherapy and Biomarkers (14 papers)Lung Cancer Treatments and Mutations (12 papers)Cancer Cells and Metastasis (5 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEFrontiers in Immunology

In The Last Decade

Guoping Cheng

38 papers receiving 802 citations

Peers

Guoping Cheng
Comparison fields: 5 of 86
  • Oncology 474
  • Pulmonary and Respiratory Medicine 332
  • Molecular Biology 216
  • Cancer Research 185
  • Immunology 152
Replace Guoliang Qiao with:
Guoliang Qiao China
Yingjie Shao China
Ignacio Matos Spain
Junzhou Wu China
Lianmin Zhang China
Pierre Bohanes United States
Limei Qu China
Roman Groisberg United States
Yoshimasa Kosaka Japan
Guoping Cheng relative to Guoliang Qiao China Guoliang Qiao's profile →
Citations per field
00.5×1.5×2.0×
Guoliang Qiao · 1×
Citations per year

Countries citing papers authored by Guoping Cheng

Since Specialization
Citations

This map shows the geographic impact of Guoping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Cheng more than expected).

Fields of papers citing papers by Guoping Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Cheng. The network helps show where Guoping Cheng may publish in the future.

Co-authorship network of co-authors of Guoping Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Guoping Cheng. A scholar is included among the top collaborators of Guoping Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoping Cheng. Guoping Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 4
3 14
4 17
5 1
6 4
7 17
8 11
9 2
10 17
11 8
12 43
13 19
14 64
15 21
16 38
17 6
18 2
19 63
20 14

About Guoping Cheng

Guoping Cheng is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 808 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (12 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Oncology (474 citations), Cancer Research (185 citations) and Pulmonary and Respiratory Medicine (332 citations). Guoping Cheng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhengbo Song, Kaiyan Chen, Yiping Zhang, Fanrong Zhang, Xinmin Yu, Yanjun Xu, Zhijian Cai, Dan Su, Jianli Wang and Huiqing Xiu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026